
CARSGEN Pharmaceuticals extends share repurchase plan, major shareholders increase holdings by 335,000 shares
CARSGEN-B (02171.HK) announced that the term of the updated share repurchase plan has been further extended until the conclusion of the next annual general meeting. From October 21 to December 17, the company has repurchased a total of 7.627 million shares.
In addition, from November 6 to December 17, the major shareholder Yijie Consortium has cumulatively purchased 335,000 shares. After the increase, the Yijie Consortium holds 38.2% of the company's total share capital

